Lookup NU author(s): Dr Laurent Kremer,
Professor Del Besra
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Tuberculosis (TB) was declared a global emergency by the WHO in 1993. Approximately one third of the world's population is infected with Mycobacterium tuberculosis. Despite the availability of effective chemotherapy, 3.5 million TB deaths occur each year. In addition to this human cost, TB also represents a significant economic burden for developing countries. The worldwide spread of TB is mainly caused by the emergence of multidrug-resistant (MDR) M. tuberculosis strains, thus underlining the need for novel antimycobacterial drugs with improved efficacy. Research in TB chemotherapy, as well as in vaccine development, has entered an intense phase in an attempt to combat this disease.
Author(s): Kremer L, Besra GS
Publication type: Editorial
Publication status: Published
Journal: Expert Opinion on Investigational Drugs
ISSN (print): 1354-3784
ISSN (electronic): 1744-7658
Publisher: Informa Healthcare